NCT02082821View on ClinicalTrials.gov

A P2X7R Single Nucleotide Mutation Promotes Chronic Allograft Vasculopathy

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

August 31, 2019

Study Completion Date

December 31, 2020

Conditions
Cardiac Allograft Vasculopathy
Trial Locations (1)

02115

Boston Children's Hospital, Boston

All Listed Sponsors
lead

Boston Children's Hospital

OTHER

NCT02082821 - A P2X7R Single Nucleotide Mutation Promotes Chronic Allograft Vasculopathy | Biotech Hunter | Biotech Hunter